Evidence map›Paper›PMID 29222839›Full record

ArticleJournal of tissue engineering and regenerative medicine2018

Decellularized human liver extracellular matrix (hDLM)-mediated hepatic differentiation of human induced pluripotent stem cells (hIPSCs).

Maria Jaramillo, Heidi Yeh, Martin L Yarmush, Basak E Uygun

Abstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Scaffold implantationAnnals of surgical treatment and research · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Maria JaramilloCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA, USA.ORCID 0000-0002-7038-720X
Heidi YehDepartment of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Martin L YarmushCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA, USA.
Basak E UygunCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA, USA.
Shriners Hospitals for Children - Erie · USMassachusetts General Hospital · USRutgers, The State University of New Jersey · US

Funding

Recellularization of Liver BioscaffoldsR01DK084053 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF, YARMUSH, MARTIN L · 2009 to 2020
$4.6M
High subzero preservation of liver for transplantationR01DK114506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET, UYGUN, KORKUT · 2017 to 2025
$4.4M
Extended Storage of Tissues and Organs in Subzero EnvironmentsR01EB008678 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI YARMUSH, MARTIN L · 2009 to 2012
$2.5M
Use of Discarded Organs for Preparation of Liver GraftsR00DK088962 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF · 2014 to 2016
$844k
Use of Discarded Organs for Preparation of Liver GraftsK99DK088962 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF · 2011 to 2012
$175k
NIBIB NIH HHS R01 EB008678NIDDK NIH HHS K99 DK088962NIDDK NIH HHS R00 DK088962NIDDK NIH HHS R01 DK084053NIDDK NIH HHS R01 DK114506
6 · The paper itself

Abstract

Liver tissue engineering has emerged as a promising approach in organ transplantation but has been hampered by the lack of a reliable and readily available cell source. Human induced pluripotent stem cells hiPSCs have been highlighted as a desirable source, due to their differentiation potential, ability to self-renew, and the possibility of making patient-specific cells. We developed a decellularization protocol that efficiently removes cellular material while retaining extracellular matrix components. Subsequently, hiPSCs were differentiated on decellularized human liver extracellular matrix (hDLM) scaffolds using an established hepatic differentiation protocol. We demonstrate that using hDLM leads to upregulation markers of hepatic functions when compared with standard differentiation conditions. In addition, expression of a number of hepatic transcription and nuclear factors were found to be within levels comparable with those of primary human adult hepatocytes. Analysis of progression of differentiation on hDLM demonstrated that hepatic developmental marker expression was consistent with hepatic development. The hDLM-derived cells exhibited key hepatic characteristics that were comparable with those observed in primary neonatal human hepatocytes. We investigated the optimal timing of the introduction of hDLM into the differentiation protocol and found that the best results are obtained when cells are plated on hDLM since the earliest stages and accompanied by a progressive loss of sensitivity to substrate composition at later stages. The significance of this work is that it allows for the development of differentiation protocols that take into account signals from extracellular matrix, closely recapitulating of the in vivo micro-environment and resulting in cells that are phenotypically closer to mature hepatocytes.

Indexed as

Cell DifferentiationAdultAntigens, DifferentiationCell LineExtracellular MatrixFemaleHumansInduced Pluripotent Stem CellsLiverMaleTissue ScaffoldsAntigens, Differentiationcell-ECM interactionsdecellularizationextracellular matrixhepatic differentiationinduced pluripotent stem cellsliver

Identifiers

PMID29222839
PMCPMC5906168
OpenAlexW2773156687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.